Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Conditions
Recurrent Glioblastoma · Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype · Relapsed Cancer · Recurrent Tumor · Glioblastoma Multiforme · Recurring Glioblastoma · Brain and Central Nervous System Tumors · Glioma · Glioblastomas · Grade IV Astrocytoma · GBM · Recurrent Glioma (Glioblastoma Multiforme) · High Grade Glioma · Glioma, Malignant · Brain Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (NIH Clinical Center Office of Patient Recruitment (OPR) · ccopr@nih.gov · 800-411-1222
Study leads
Sadhana Jackson, M.D.
Principal Investigator
National Institute of Neurological Disorders and Stroke (NINDS)